| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.39B | 16.27B | 4.67B | 9.21B | 4.87B |
| Gross Profit | 6.04B | 5.18B | 4.67B | 4.76B | 3.95B |
| EBITDA | 2.18B | 2.89B | 2.23B | -57.00M | 1.76B |
| Net Income | 1.06B | 2.30B | 1.30B | 1.66B | 1.25B |
Balance Sheet | |||||
| Total Assets | 382.33B | 367.88B | 271.92B | 271.89B | 272.35B |
| Cash, Cash Equivalents and Short-Term Investments | 38.41B | 29.48B | 25.16B | 25.64B | 30.22B |
| Total Debt | 65.43B | 54.24B | 54.89B | 61.17B | 72.07B |
| Total Liabilities | 363.22B | 347.39B | 254.23B | 256.32B | 257.99B |
| Stockholders Equity | 18.91B | 19.72B | 17.69B | 16.91B | 15.70B |
Cash Flow | |||||
| Free Cash Flow | 3.48B | -8.31B | 7.08B | 1.80B | 1.07B |
| Operating Cash Flow | 3.90B | -7.91B | 7.17B | 2.14B | 1.35B |
| Investing Cash Flow | 2.33B | 10.77B | 792.00M | -4.21B | -4.96B |
| Financing Cash Flow | 2.12B | 1.44B | -9.31B | -2.79B | 16.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £1.55B | 12.29 | 11.24% | 11.03% | 2.58% | -12.71% | |
70 Outperform | £135.16M | 7.65 | 6.53% | 5.68% | -4.79% | -28.34% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £61.73B | 12.33 | 10.75% | 3.41% | -18.98% | 23.57% | |
65 Neutral | £1.45B | 8.21 | 12.75% | 4.74% | -6.82% | -7.03% | |
58 Neutral | £1.14B | 16.31 | 5.16% | ― | -10.71% | 23.10% | |
57 Neutral | £1.36B | 1.11 | 11.68% | ― | 7.19% | -54.08% |